[Asia Economy Reporter Park Jihwan] Pharmicell announced on the 6th that it has decided to invest 10.6 billion KRW in new facilities to expand the raw pharmaceutical ingredient production equipment at its Ulsan plant.



This amount corresponds to 20.62% of the company's equity capital based on last year's separate financial statements.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing